BACKGROUND
COVID-19 Pneumonia was initially described in China and quickly became a
pandemic with high morbidity and significant social and financial loss.
(1) More than 70% of COVID-19 infections are mild, 20% require
hospitalization, and 5% need intensive therapy. (2, 3) Post-organ
transplant patients are at a higher risk of developing COVID-19
infection due to immunosuppression. These patients are also at a higher
risk for severe COVID-19 infection and its complications than the
general population. (4, 5) Cardiac transplant recipients’ are at a
higher risk of developing COVID-19 infection due to having multiple
comorbidities and receiving immunosuppression therapy. (6)
We are reporting a case of COVID-19 infection in cardiac transplant
recipient patients as well as reviewing the available literature.